ATE516019T1 - Quellbare dosierform mit gellan-gummit - Google Patents
Quellbare dosierform mit gellan-gummitInfo
- Publication number
- ATE516019T1 ATE516019T1 AT05739537T AT05739537T ATE516019T1 AT E516019 T1 ATE516019 T1 AT E516019T1 AT 05739537 T AT05739537 T AT 05739537T AT 05739537 T AT05739537 T AT 05739537T AT E516019 T1 ATE516019 T1 AT E516019T1
- Authority
- AT
- Austria
- Prior art keywords
- dosage form
- spindle
- glucose
- viscosity
- oral administration
- Prior art date
Links
- 239000002552 dosage form Substances 0.000 title abstract 4
- 229920002148 Gellan gum Polymers 0.000 title abstract 3
- 239000000203 mixture Substances 0.000 abstract 3
- 239000012736 aqueous medium Substances 0.000 abstract 2
- 235000010492 gellan gum Nutrition 0.000 abstract 2
- 239000000216 gellan gum Substances 0.000 abstract 2
- 239000000463 material Substances 0.000 abstract 2
- 239000002253 acid Substances 0.000 abstract 1
- 239000013543 active substance Substances 0.000 abstract 1
- 239000002775 capsule Substances 0.000 abstract 1
- 239000003795 chemical substances by application Substances 0.000 abstract 1
- 239000003792 electrolyte Substances 0.000 abstract 1
- 239000000499 gel Substances 0.000 abstract 1
- 150000007524 organic acids Chemical class 0.000 abstract 1
- 235000005985 organic acids Nutrition 0.000 abstract 1
- 239000002357 osmotic agent Substances 0.000 abstract 1
- 229920000642 polymer Polymers 0.000 abstract 1
- 239000007787 solid Substances 0.000 abstract 1
- 230000008961 swelling Effects 0.000 abstract 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
- A61K9/1605—Excipients; Inactive ingredients
- A61K9/1629—Organic macromolecular compounds
- A61K9/1652—Polysaccharides, e.g. alginate, cellulose derivatives; Cyclodextrin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61J—CONTAINERS SPECIALLY ADAPTED FOR MEDICAL OR PHARMACEUTICAL PURPOSES; DEVICES OR METHODS SPECIALLY ADAPTED FOR BRINGING PHARMACEUTICAL PRODUCTS INTO PARTICULAR PHYSICAL OR ADMINISTERING FORMS; DEVICES FOR ADMINISTERING FOOD OR MEDICINES ORALLY; BABY COMFORTERS; DEVICES FOR RECEIVING SPITTLE
- A61J7/00—Devices for administering medicines orally, e.g. spoons; Pill counting devices; Arrangements for time indication or reminder for taking medicine
- A61J7/0015—Devices specially adapted for taking medicines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61J—CONTAINERS SPECIALLY ADAPTED FOR MEDICAL OR PHARMACEUTICAL PURPOSES; DEVICES OR METHODS SPECIALLY ADAPTED FOR BRINGING PHARMACEUTICAL PRODUCTS INTO PARTICULAR PHYSICAL OR ADMINISTERING FORMS; DEVICES FOR ADMINISTERING FOOD OR MEDICINES ORALLY; BABY COMFORTERS; DEVICES FOR RECEIVING SPITTLE
- A61J7/00—Devices for administering medicines orally, e.g. spoons; Pill counting devices; Arrangements for time indication or reminder for taking medicine
- A61J7/0015—Devices specially adapted for taking medicines
- A61J7/0023—Spoons
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61J—CONTAINERS SPECIALLY ADAPTED FOR MEDICAL OR PHARMACEUTICAL PURPOSES; DEVICES OR METHODS SPECIALLY ADAPTED FOR BRINGING PHARMACEUTICAL PRODUCTS INTO PARTICULAR PHYSICAL OR ADMINISTERING FORMS; DEVICES FOR ADMINISTERING FOOD OR MEDICINES ORALLY; BABY COMFORTERS; DEVICES FOR RECEIVING SPITTLE
- A61J7/00—Devices for administering medicines orally, e.g. spoons; Pill counting devices; Arrangements for time indication or reminder for taking medicine
- A61J7/0015—Devices specially adapted for taking medicines
- A61J7/0046—Cups, bottles or bags
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/16—Amides, e.g. hydroxamic acids
- A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
- A61K31/167—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide having the nitrogen of a carboxamide group directly attached to the aromatic ring, e.g. lidocaine, paracetamol
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/192—Carboxylic acids, e.g. valproic acid having aromatic groups, e.g. sulindac, 2-aryl-propionic acids, ethacrynic acid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/4415—Pyridoxine, i.e. Vitamin B6
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
- A61K9/0056—Mouth soluble or dispersible forms; Suckable, eatable, chewable coherent forms; Forms rapidly disintegrating in the mouth; Lozenges; Lollipops; Bite capsules; Baked products; Baits or other oral forms for animals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
- A61K9/2077—Tablets comprising drug-containing microparticles in a substantial amount of supporting matrix; Multiparticulate tablets
- A61K9/2081—Tablets comprising drug-containing microparticles in a substantial amount of supporting matrix; Multiparticulate tablets with microcapsules or coated microparticles according to A61K9/50
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2013—Organic compounds, e.g. phospholipids, fats
- A61K9/2018—Sugars, or sugar alcohols, e.g. lactose, mannitol; Derivatives thereof, e.g. polysorbates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2022—Organic macromolecular compounds
- A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
- A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2022—Organic macromolecular compounds
- A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
- A61K9/2059—Starch, including chemically or physically modified derivatives; Amylose; Amylopectin; Dextrin
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DKPA200400755 | 2004-05-11 | ||
PCT/DK2005/000317 WO2005107713A2 (en) | 2004-05-11 | 2005-05-11 | Swellable dosage form comprising gellan gum |
Publications (1)
Publication Number | Publication Date |
---|---|
ATE516019T1 true ATE516019T1 (de) | 2011-07-15 |
Family
ID=34967246
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AT05739537T ATE516019T1 (de) | 2004-05-11 | 2005-05-11 | Quellbare dosierform mit gellan-gummit |
Country Status (8)
Country | Link |
---|---|
US (2) | US8383154B2 (de) |
EP (2) | EP1758557B1 (de) |
JP (1) | JP5154924B2 (de) |
AT (1) | ATE516019T1 (de) |
CA (1) | CA2566793C (de) |
DK (2) | DK1758557T3 (de) |
ES (2) | ES2370729T3 (de) |
WO (1) | WO2005107713A2 (de) |
Families Citing this family (70)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6733780B1 (en) | 1999-10-19 | 2004-05-11 | Genzyme Corporation | Direct compression polymer tablet core |
WO2003024430A1 (en) | 2001-09-21 | 2003-03-27 | Egalet A/S | Morphine polymer release system |
US20040234602A1 (en) | 2001-09-21 | 2004-11-25 | Gina Fischer | Polymer release system |
EP1610767B1 (de) | 2003-03-26 | 2011-01-19 | Egalet A/S | Morphin-system mit kontrollierter freisetzung |
US7985418B2 (en) | 2004-11-01 | 2011-07-26 | Genzyme Corporation | Aliphatic amine polymer salts for tableting |
US20060275366A1 (en) * | 2005-06-02 | 2006-12-07 | Schering Corporation | Controlled-release formulation |
CN101272762B (zh) | 2005-09-15 | 2013-02-06 | 基酶有限公司 | 胺聚合物的小袋制剂 |
EP1937414A4 (de) * | 2005-09-19 | 2013-01-02 | Univ Witwatersrand Jhb | Oromucosale arzneimittelverabreichungsform |
US20100291205A1 (en) * | 2007-01-16 | 2010-11-18 | Egalet A/S | Pharmaceutical compositions and methods for mitigating risk of alcohol induced dose dumping or drug abuse |
US20160331729A9 (en) | 2007-04-11 | 2016-11-17 | Omeros Corporation | Compositions and methods for prophylaxis and treatment of addictions |
US11241420B2 (en) | 2007-04-11 | 2022-02-08 | Omeros Corporation | Compositions and methods for prophylaxis and treatment of addictions |
NZ580972A (en) | 2007-06-04 | 2012-02-24 | Egalet Ltd | Controlled release pharmaceutical compositions for prolonged effect |
US8563066B2 (en) | 2007-12-17 | 2013-10-22 | New World Pharmaceuticals, Llc | Sustained release of nutrients in vivo |
CN102014973A (zh) | 2008-02-29 | 2011-04-13 | 弗罗桑医疗设备公司 | 用于促进止血和/或伤口愈合的装置 |
US9237972B2 (en) * | 2008-12-16 | 2016-01-19 | Kimberly-Clark Worldwide, Inc. | Liquid surfactant compositions that adhere to surfaces and solidify and swell in the presence of water and articles using the same |
EP2208493A1 (de) | 2009-01-15 | 2010-07-21 | Sandoz AG | Verfahren und Vorrichtung zur oralen Anwendung einer Zusammensetzung |
CA2750400A1 (en) * | 2009-01-26 | 2010-07-29 | Egalet A/S | Controlled release formulations with continuous efficacy |
CA2751667C (en) | 2009-02-06 | 2016-12-13 | Egalet Ltd. | Immediate release composition resistant to abuse by intake of alcohol |
NZ594208A (en) * | 2009-02-06 | 2012-10-26 | Egalet Ltd | Pharmaceutical compositions resistant to abuse |
BRPI1009141A2 (pt) | 2009-03-11 | 2016-03-08 | Omeros Corp | composições e métodos para profilaxia e tratamento de vícios |
EP2445487A2 (de) | 2009-06-24 | 2012-05-02 | Egalet Ltd. | Retard-formulierungen |
FR2955252B1 (fr) * | 2010-01-21 | 2012-03-23 | Patrick Lesage | Materiau d'insertion destine a elargir le sillon gingival |
CA2790248A1 (en) | 2010-03-15 | 2011-09-22 | Ferrosan Medical Devices A/S | A method for promotion of hemostasis and/or wound healing |
SG188509A1 (en) | 2010-09-13 | 2013-04-30 | Bev Rx Inc | Aqueous drug delivery system comprising off - flavor masking agent |
US9132291B2 (en) | 2010-10-05 | 2015-09-15 | Dfb Technology, Ltd. | Water-in-oil emulsion compositions containing gellan gum for topical delivery of active ingredients to the skin or mucosa |
WO2012103411A2 (en) | 2011-01-28 | 2012-08-02 | Zx Pharma, Llc | Controlled-release melatonin composition and related methods |
US9532952B2 (en) | 2011-01-28 | 2017-01-03 | Physician's Seal, LLC | Controlled-release compositions of melatonin combined with sedative and/or analgesic ingredients |
US8808736B2 (en) | 2011-02-11 | 2014-08-19 | Zx Pharma, Llc | Enteric coated multiparticulate controlled release peppermint oil composition and related methods |
US8911780B2 (en) | 2011-02-11 | 2014-12-16 | Zx Pharma, Llc | Multiparticulate L-menthol formulations and related methods |
PT2672981T (pt) | 2011-02-11 | 2018-06-21 | Zx Pharma Llc | Dispersão de partículas de polímero num meio não aquoso |
JP5226097B2 (ja) * | 2011-03-30 | 2013-07-03 | 株式会社ファンケル | サプリメントを内包する蓋体とサプリメント分散媒を充填したボトルからなるボトル入り飲料 |
US9119793B1 (en) | 2011-06-28 | 2015-09-01 | Medicis Pharmaceutical Corporation | Gastroretentive dosage forms for doxycycline |
US8898912B2 (en) * | 2011-08-29 | 2014-12-02 | Adam Leffler | Spoon delivery device |
WO2013058996A1 (en) | 2011-10-19 | 2013-04-25 | R.P. Scherer Technologies, Llc | Two phase pharmaceutical delivery system |
WO2013095215A1 (en) * | 2011-12-19 | 2013-06-27 | Dilaforette Ab | Low anticoagulant heparins |
EP2822474B1 (de) | 2012-03-06 | 2018-05-02 | Ferrosan Medical Devices A/S | Druckbehälter mit einer blutstillenden paste |
AU2013235266B2 (en) | 2012-03-20 | 2017-10-19 | Particle Dynamics International, Llc | Gelling agent-based dosage form |
WO2013169925A1 (en) * | 2012-05-08 | 2013-11-14 | Metronomx | Novel formulations of nitrofurans including nifurtimox with enhanced activity with lower toxicity |
BR112014030962A2 (pt) | 2012-06-12 | 2017-06-27 | Ferrosan Medical Devices As | métodos para preparação e para reconstituição de uma composição seca adequada para uso em hemostase e cicatrização de feridas, e, kit hemostático |
CA2877183A1 (en) | 2012-07-06 | 2014-01-09 | Egalet Ltd. | Abuse deterrent pharmaceutical compositions for controlled release |
EP2934422A4 (de) * | 2012-12-23 | 2016-07-20 | Vadim Zelikman | Gellangummiträger für ein medikament, mittel und verfahren |
US10842802B2 (en) | 2013-03-15 | 2020-11-24 | Medicis Pharmaceutical Corporation | Controlled release pharmaceutical dosage forms |
CA2909591C (en) | 2013-04-23 | 2017-03-28 | Zx Pharma, Llc | Enteric coated multiparticulate composition with proteinaceous subcoat |
US9724078B2 (en) | 2013-06-21 | 2017-08-08 | Ferrosan Medical Devices A/S | Vacuum expanded dry composition and syringe for retaining same |
KR20160023695A (ko) * | 2013-06-26 | 2016-03-03 | 유니버시티 오브 아이오와 리써치 파운데이션 | 구강 약물 전달 디바이스 및 그 사용 방법 |
EP3470094B1 (de) | 2013-12-11 | 2020-07-22 | Ferrosan Medical Devices A/S | Trockenzusammensetzung mit extrusionsverstärker |
CA2939082C (en) | 2014-02-13 | 2022-06-07 | Incyte Corporation | Cyclopropylamines as lsd1 inhibitors |
ME03580B (de) | 2014-02-13 | 2020-07-20 | Incyte Corp | Cyclopropylamine als lsd1-hemmer |
CA2943422C (en) | 2014-04-29 | 2020-03-10 | The Procter & Gamble Company | Bismuth-containing liquid pharmaceutical suspensions |
WO2016007722A1 (en) | 2014-07-10 | 2016-01-14 | Incyte Corporation | Triazolopyridines and triazolopyrazines as lsd1 inhibitors |
CN105560281A (zh) * | 2014-10-08 | 2016-05-11 | 华仁药业股份有限公司 | 一种混合糖电解质注射液及其制备方法 |
WO2016058612A1 (en) | 2014-10-13 | 2016-04-21 | Ferrosan Medical Devices A/S | Dry composition for use in haemostasis and wound healing |
WO2016102446A1 (en) | 2014-12-24 | 2016-06-30 | Ferrosan Medical Devices A/S | Syringe for retaining and mixing first and second substances |
WO2016130908A1 (en) * | 2015-02-13 | 2016-08-18 | The University Of Toledo | Therapeutic polysaccharide midi-gagr and related materials and methods |
TWI714567B (zh) | 2015-04-03 | 2021-01-01 | 美商英塞特公司 | 作為lsd1抑制劑之雜環化合物 |
EP3288556A4 (de) | 2015-04-29 | 2018-09-19 | Dexcel Pharma Technologies Ltd. | Oral zerfallende zusammensetzungen |
JO3456B1 (ar) | 2015-05-13 | 2020-07-05 | H Lundbeck As | فيروتيوكسيتين بيروجلوتامات |
GR1008819B (el) | 2015-05-22 | 2016-08-01 | Φαρματεν Ανωνυμος Βιομηχανικη Και Εμπορικη Εταιρεια Φαρμακευτικων Ιατρικων Και Καλλυντικων Προϊοντων | Φαρμακευτικο σκευασμα που περιλαμβανει ατομοξετινη και μεθοδος παρασκευης αυτου |
WO2017005590A1 (en) | 2015-07-03 | 2017-01-12 | Ferrosan Medical Devices A/S | Syringe for mixing two components and for retaining a vacuum in a storage condition |
CR20180152A (es) | 2015-08-12 | 2018-08-09 | Incyte Corp | Sales de un inhibidor de lsd1 |
KR20190008265A (ko) | 2016-05-06 | 2019-01-23 | 피지션즈 씰, 엘엘씨 | 발레리안 조성물 및 관련 방법 |
US10076494B2 (en) | 2016-06-16 | 2018-09-18 | Dexcel Pharma Technologies Ltd. | Stable orally disintegrating pharmaceutical compositions |
US10806789B2 (en) * | 2017-05-12 | 2020-10-20 | The LIV Group Inc. | Composition for enhanced absorption of supplements |
EP4321182A2 (de) | 2018-05-09 | 2024-02-14 | Ferrosan Medical Devices A/S | Verfahren zur herstellung einer hämostatischen zusammensetzung |
WO2020047198A1 (en) | 2018-08-31 | 2020-03-05 | Incyte Corporation | Salts of an lsd1 inhibitor and processes for preparing the same |
EP3699223A1 (de) * | 2019-02-19 | 2020-08-26 | LANXESS Deutschland GmbH | Inline ultraschallkontrolle zur detektion des anvernetzens einer kautschukmischung bei der in situ silanisierung von hellen füllstoffen |
US20220400724A1 (en) * | 2019-10-28 | 2022-12-22 | R.P. Scherer Technologies, Llc | Delayed release softgel capsules in higher ph environment |
CA3178341A1 (en) | 2020-07-10 | 2022-01-13 | Adare Pharmaceuticals, Inc. | Swellable oral pharmaceutical compositions |
WO2022187511A1 (en) * | 2021-03-03 | 2022-09-09 | Veramorph Llc | Dissociating polymer matrix compositions of fulvestrant and methods of their making and use |
WO2023038575A2 (en) * | 2021-09-09 | 2023-03-16 | Junion Labs Pte. Ltd. | Superabsorbent hydrogels with lipase inhibitor |
Family Cites Families (27)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4994260A (en) | 1982-05-28 | 1991-02-19 | Astra Lakemedel Aktiebolag | Pharmaceutical mixture |
US4590075A (en) | 1984-08-27 | 1986-05-20 | Warner-Lambert Company | Elastomer encapsulation of flavors and sweeteners, long lasting flavored chewing gum compositions based thereon and process of preparation |
US4824681A (en) | 1986-12-19 | 1989-04-25 | Warner-Lambert Company | Encapsulated sweetener composition for use with chewing gum and edible products |
GB8702411D0 (en) | 1987-02-03 | 1987-03-11 | Zyma Sa | Swellable pellets |
US5234957A (en) | 1991-02-27 | 1993-08-10 | Noven Pharmaceuticals, Inc. | Compositions and methods for topical administration of pharmaceutically active agents |
US5178878A (en) | 1989-10-02 | 1993-01-12 | Cima Labs, Inc. | Effervescent dosage form with microparticles |
WO1992011084A1 (en) | 1990-12-17 | 1992-07-09 | Redding Bruce K Jr | Microencapsulated sweeteners for use in baked goods |
US5126151A (en) | 1991-01-24 | 1992-06-30 | Warner-Lambert Company | Encapsulation matrix |
IL108366A (en) * | 1993-03-11 | 1999-11-30 | Taro Vit Ind Ltd | Semi-solid pharmaceutical compounds and a device for their use |
US5881926A (en) | 1993-03-11 | 1999-03-16 | Taro Pharmaceutical Industries, Ltd. | Pharmaceutical compositions in semisolid form and a device for administration thereof |
ES2217410T3 (es) | 1996-04-16 | 2004-11-01 | Novartis Consumer Health S.A. | Forma de dosificacion oral de rapida desintegracion. |
US6709678B2 (en) * | 1996-08-15 | 2004-03-23 | Losan Pharma Gmbh | Easy to swallow oral medicament composition |
CA2273206A1 (en) | 1996-11-29 | 1998-06-04 | Monsanto Company | Lubricious self-standing (intact) gel for oral delivery of biologically-active ingredients |
US6395298B1 (en) * | 1997-10-31 | 2002-05-28 | Pharmacia Corporation | Gellan gum tablet coating |
JP3524359B2 (ja) | 1997-12-26 | 2004-05-10 | 伊那食品工業株式会社 | 咀嚼・嚥下困難者用の摂食補助用糊料 |
US6071523A (en) * | 1998-06-03 | 2000-06-06 | Taro Pharmaceuticals Industries, Ltd. | Spill resistant pharmaceutical compositions in semi-solid form |
SK284948B6 (sk) | 2000-04-06 | 2006-03-02 | Zentiva, A. S. | Liečivý prípravok s obsahom vápnika alebo zmesi vápnika a vitamínu D, alebo zmesi vápnika a horčíka v novej liekovej forme |
US6488962B1 (en) | 2000-06-20 | 2002-12-03 | Depomed, Inc. | Tablet shapes to enhance gastric retention of swellable controlled-release oral dosage forms |
US6474418B2 (en) | 2000-12-07 | 2002-11-05 | Frank's International, Inc. | Wellbore fluid recovery system and method |
EP1353649A2 (de) | 2000-12-21 | 2003-10-22 | Oscar M. Bassinson | Karte zur abgabe von personengebundenen medikamenten |
US6589955B2 (en) | 2001-06-20 | 2003-07-08 | Bristol-Myers Squibb Company | Pediatric formulation of gatifloxacin |
CN100408029C (zh) * | 2001-09-28 | 2008-08-06 | 麦克内尔-Ppc股份有限公司 | 有镶嵌部分的组合剂型 |
HRP20020924A2 (en) | 2001-11-23 | 2003-10-31 | Glaxo Group Ltd | Pharmaceutical composition |
JP3835544B2 (ja) * | 2002-09-10 | 2006-10-18 | 明治乳業株式会社 | ゼリー乾燥物 |
AU2004234584B2 (en) | 2003-04-25 | 2009-05-21 | Reckitt Benckiser Healthcare (Uk) Limited | Thickenable compositions |
CA2533165A1 (en) | 2003-07-21 | 2005-01-27 | Bio-Dar Ltd. | Gellan gum based oral controlled release dosage forms- a novel platform technology for gastric retention |
US9109434B2 (en) | 2013-06-09 | 2015-08-18 | Schlumberger Technology Corporation | System and method for estimating oil formation volume factor downhole |
-
2005
- 2005-05-11 WO PCT/DK2005/000317 patent/WO2005107713A2/en active Application Filing
- 2005-05-11 US US11/596,123 patent/US8383154B2/en active Active
- 2005-05-11 ES ES05739537T patent/ES2370729T3/es active Active
- 2005-05-11 AT AT05739537T patent/ATE516019T1/de active
- 2005-05-11 JP JP2007511867A patent/JP5154924B2/ja not_active Expired - Fee Related
- 2005-05-11 EP EP05739537A patent/EP1758557B1/de active Active
- 2005-05-11 DK DK05739537.8T patent/DK1758557T3/da active
- 2005-05-11 EP EP10175613.8A patent/EP2258349B1/de active Active
- 2005-05-11 DK DK10175613.8T patent/DK2258349T3/da active
- 2005-05-11 ES ES10175613.8T patent/ES2517244T3/es active Active
- 2005-05-11 CA CA2566793A patent/CA2566793C/en active Active
-
2011
- 2011-08-18 US US13/212,679 patent/US8383155B2/en active Active
Also Published As
Publication number | Publication date |
---|---|
WO2005107713A2 (en) | 2005-11-17 |
US20080299199A1 (en) | 2008-12-04 |
JP2007537169A (ja) | 2007-12-20 |
US8383155B2 (en) | 2013-02-26 |
CA2566793C (en) | 2013-07-16 |
DK1758557T3 (da) | 2011-10-24 |
ES2370729T3 (es) | 2011-12-22 |
EP1758557B1 (de) | 2011-07-13 |
US20120039969A1 (en) | 2012-02-16 |
EP2258349A3 (de) | 2012-04-04 |
EP2258349A2 (de) | 2010-12-08 |
US8383154B2 (en) | 2013-02-26 |
EP1758557A2 (de) | 2007-03-07 |
ES2517244T3 (es) | 2014-11-03 |
CA2566793A1 (en) | 2005-11-17 |
DK2258349T3 (da) | 2014-10-13 |
EP2258349B1 (de) | 2014-07-16 |
WO2005107713A3 (en) | 2006-05-18 |
JP5154924B2 (ja) | 2013-02-27 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ATE516019T1 (de) | Quellbare dosierform mit gellan-gummit | |
Teng et al. | Recent development of alginate-based materials and their versatile functions in biomedicine, flexible electronics, and environmental uses | |
JP4959328B2 (ja) | 温度感応性状態変化ハイドロゲル組成物及びその製造方法 | |
US20210361822A1 (en) | Functional wound dressing | |
US11937922B2 (en) | pH-triggered diagnostic wound dressing | |
Guyot et al. | Injectable, strong and bioadhesive catechol-chitosan hydrogels physically crosslinked using sodium bicarbonate | |
ES2355613T3 (es) | Composiciones en dos fases de polímero hidrofóbico superabsorbente. | |
EP3643331A1 (de) | Ph-ausgelöster therapeutischer wundverband | |
Gomaa et al. | Laser-engineered dissolving microneedles for active transdermal delivery of nadroparin calcium | |
EP3643330A1 (de) | Ph-ausgelöste gepufferte wundauflage | |
BRPI0907965B1 (pt) | produto para instalações sanitárias, seus usos e conjunto de limpeza para vaso sanitário compreendendo o mesmo | |
BR112018069184B1 (pt) | Composição de um ou vários componentes para a produção de um hidrogel, método para a produção de um hidrogel (met)acrílico, hidrogel (met)acrílico, material para a injeção de (met) acrílico, e método para a vedação e/ou o preenchimento de fissuras, vazios, falhas e cavidades em uma estrutura de edifício | |
AU2016347548A1 (en) | Composite bioadhesive sealant | |
CN104258474B (zh) | 一种含有离子交换功能基团的栓塞微球及其制备方法 | |
WO2010117266A1 (en) | In situ gelling alginate systems | |
AU2004212746B2 (en) | Bioadhesive liquid composition which is substantially free of water | |
Silva et al. | Dissolvable Carboxymethylcellulose Microneedles for Noninvasive and Rapid Administration of Diclofenac Sodium | |
Raza et al. | Injectable zein gel with in situ self-assembly as hemostatic material | |
Naharros‐Molinero et al. | Shell formulation in soft gelatin capsules: Design and characterization | |
BR112018071272B1 (pt) | Hidrogel (met)acrílico, método para produzir o referido hidrogel (met)acrílico, método para vedação e/ou preenchimento de fissuras, espaços vazios, falhas e cavidades em uma estrutura de construção | |
Viyoch et al. | Formulation and development of a patch containing tamarind fruit extract by using the blended chitosan–starch as a rate‐controlling matrix | |
CN103463125B (zh) | 治疗妇科疾病的凝胶制剂及其制备方法 | |
Sosnowska et al. | The effect of PAMAM dendrimers with amine or hydroxyl terminal groups on the bioadhesive properties of hydrogels with clotrimazole | |
KR20160101957A (ko) | 제어가능하게 분해가능한 조성물 및 방법 | |
US20230139406A1 (en) | Breakable galenic capsule |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
UEP | Publication of translation of european patent specification |
Ref document number: 1758557 Country of ref document: EP |